Search for: "Novartis International AG" Results 1 - 20 of 120
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending… [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
3 Nov 2015, 12:13 pm by Fraud Fighters
Novartis AG, a European based pharmaceutical company, agreed to settle a False Claims Act (FCA) lawsuit for $390 million, a week before the original $3.3 billion FCA lawsuit was set to go to trial on November 2, 2015. [read post]
13 Aug 2020, 7:34 am by Geoff Schweller
  One of the newly posted Notices refers to a case where the SEC and Novartis AG (Novartis) settled charges that Novartis violated the Foreign and Corrupt Practices Act (FCPA). [read post]
7 Apr 2013, 9:37 pm by Patent Docs
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Feb 2014, 9:51 pm by Patent Docs
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
3 Nov 2015, 9:00 am
(Novartis), a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Switzerland, agreed to pay a whopping $390 million as a "settlement in principle" to resolve a False Claims Act (FCA) suit. [read post]
16 Jan 2014, 7:31 pm
  Procedural HistoryNovartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. [read post]
3 Jul 2019, 11:02 am
Barbara Levi Mager is a longtime in-house leader for Swiss pharmaceutical company Novartis International AG and Sandoz, a division of Novartis. [read post]
19 Aug 2010, 9:02 pm
Depending on the product in question, competition concerns arose in either a few or a larger number of EC member states.The FTC complaint and proposed consent order, In the Matter of Novartis AG, FTC Dkt. [read post]
23 Sep 2010, 9:36 am by John Tucker
Food and Drug Administration ("FDA") approved Fingolimod capsules (Gilenya, Novartis International AG) for reducing the frequency of relapses and delaying the accumulation of disabling symptoms in relapsing forms of Multiple Sclerosis ("MS"). [read post]
10 Jan 2012, 3:00 am
In 2010, Novartis International AG, a major manufacturer of generic prescription drugs, recorded sales of $46.806 billion. [read post]
25 Jun 2020, 12:07 pm by Mary Jane Wilmoth
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]
14 Nov 2021, 8:59 pm by Patent Docs
Sir Robin Jacob, Sir Hugh Laddie Chair of Intellectual Property Law, University College London; Ansgar Ohly, Professor, Ludwig Maximilian University of Munich; Roberto Rodrigues of Licks Attorneys; and Corey Salsberg of Novartis International AG. [read post]
17 Jun 2020, 1:15 pm by Tom Lamb
From this June 12, 2020 news article, "Beovu Labeling Updated With Additional Safety Information", we get the following details: The update is based on a recent internal review conducted by Novartis of adverse events observed in the HAWK & HARRIER clinical trials, including rare postmarketing safety reports of vasculitis. [read post]